| 4.25 0.01 (0.24%) | 04-22 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.8 | 1-year : | 8.02 |
| Resists | First : | 5.83 | Second : | 6.87 |
| Pivot price | 4.65  |
|||
| Supports | First : | 4.13 | Second : | 3.44 |
| MAs | MA(5) : | 4.28 |
MA(20) : | 4.92 |
| MA(100) : | 5.96 |
MA(250) : | 6.07 |
|
| MACD | MACD : | -0.5  |
Signal : | -0.5 |
| %K %D | K(14,3) : | 8.5 |
D(3) : | 8.4 |
| RSI | RSI(14): 32 |
|||
| 52-week | High : | 9.11 | Low : | 4.13 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ EXAI ] has closed above bottom band by 17.8%. Bollinger Bands are 20.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.38 - 4.4 | 4.4 - 4.42 |
| Low: | 4.12 - 4.15 | 4.15 - 4.17 |
| Close: | 4.21 - 4.25 | 4.25 - 4.28 |
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Mon, 22 Apr 2024
Exscientia plc Calls for 2024 Shareholder Votes - TipRanks.com - TipRanks
Thu, 21 Mar 2024
Exscientia Plc Reports Progressive Drug Pipeline - TipRanks.com - TipRanks
Thu, 21 Mar 2024
Exscientia Business and Financial Update for the Full Year 2023 - Business Wire
Tue, 19 Mar 2024
Exscientia plc's (NASDAQ:EXAI) market cap touched US$797m last week, benefiting both individual investors who own ... - Yahoo Finance
Thu, 14 Mar 2024
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024 - Yahoo Finance
Wed, 13 Mar 2024
Is Exscientia PLC (EXAI) Stock at the Top of the Biotechnology Industry? - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 126 (M) |
| Held by Insiders | 9.258e+007 (%) |
| Held by Institutions | 26.4 (%) |
| Shares Short | 3,230 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.6252e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 789.9 % |
| Return on Equity (ttm) | -18.8 % |
| Qtrly Rev. Growth | 2.008e+007 % |
| Gross Profit (p.s.) | -82.44 |
| Sales Per Share | -44.85 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -118 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.1 |
| Price to Cash Flow | 1.17 |
| Dividend | 0 |
| Forward Dividend | 4.36e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|